— Know what they know.
Not Investment Advice

SOPH

SOPHiA GENETICS S.A.
1W: +7.6% 1M: +2.5% 3M: +6.4% YTD: +6.2% 1Y: +65.3% 3Y: +2.1%
$4.96
+0.10 (+2.06%)
After Hours: $4.72 (-0.24, -4.74%)
NASDAQ · Healthcare · Medical - Healthcare Information Services · $355.5M · Alpha Radar Neutral · Power 53
Smart Money Score
Moderate 50
Insider
Congress
ETF Holdings
Key Statistics
Market Cap$355.5M
52W Range2.58-5.7
Volume119,784
Avg Volume193,367
Beta1.14
Dividend
Analyst Ratings
6 Buy 1 Hold 0 Sell
Consensus Buy
Company Info
CEOJurgi Camblong
Employees423
SectorHealthcare
IndustryMedical - Healthcare Information Services
IPO Date2021-07-23
Rue du Centre 172
Rolle 1025
CH
41 21 694 10 60
About SOPHiA GENETICS S.A.

SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory, and biopharma worldwide. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Saint-Sulpice, Switzerland.

Recent Insider Trades

NameTypeSharesPriceDate
Van Well Daan S-Sale 684 $4.79 2026-03-19
Camblong Jurgi S-Sale 4,486 $4.77 2026-03-19
Menu Philippe S-Sale 608 $4.79 2026-03-19
Xu Zhenyu S-Sale 608 $4.78 2026-03-19
Valente Manuela S-Sale 380 $4.79 2026-03-19

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms